Ocular Hypotensive Efficacy and Safety of the Rho Kinase Inhibitor AR-12286 in Patients With Elevated Intraocular Pressure

被引：0
|
作者：
Williams, R. D. [1 ]
Novack, G. D. [2 ]
van Haarlem, T. [3 ]
Kopczynski, C. [4 ]
机构：
[1] Clin Res Ctr, Louisville, KY USA
[2] PharmaLog Dev Inc, San Rafael, CA USA
[3] Aerie Pharmaceut Inc, Bridgewater, NJ USA
[4] Aerie Pharmaceut Inc, Res Triangle Pk, NC USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
intraocular pressure; trabecular meshwork; clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1633
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of the ocular hypotensive lipid™ AGN 192024 in patients with elevated IOP:: A 30-day comparison with latanoprost
    Dirks, M
    DuBiner, H
    Cooke, D
    Stewart, W
    Drain, C
    Felix, C
    VanDenburgh, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S514 - S514
  • [22] Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study
    Ozturk, Faruk
    Ermis, Sitki Samet
    Inan, Umit Ubeyt
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (01): : 80 - 83
  • [23] Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension
    Katz, L. Jay
    Simmons, Steven T.
    Craven, E. Randy
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (12) : 2971 - 2983
  • [24] Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2)
    Serle, Janet B.
    Katz, L. Jay
    McLaurin, Eugene
    Heah, Theresa
    Ramirez-Davis, Nancy
    Usner, Dale W.
    Novack, Gary D.
    Kopczynski, Casey C.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 186 : 116 - 127
  • [25] Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
    Takashi Komizo
    Takashi Ono
    Akiko Yagi
    Kazunori Miyata
    Makoto Aihara
    Japanese Journal of Ophthalmology, 2019, 63 : 40 - 45
  • [26] Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma
    Komizo, Takashi
    Ono, Takashi
    Yagi, Akiko
    Miyata, Kazunori
    Aihara, Makoto
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2019, 63 (01) : 40 - 45
  • [27] Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure
    Shin, DH
    Feldman, RM
    Sheu, WP
    OPHTHALMOLOGY, 2004, 111 (02) : 276 - 282
  • [28] Changes in ocular hypotensive effect of Rho-associated protein kinase inhibitor, Ripasudil, with pilocarpine and timolol in rabbit eye
    Mizuno, Yu
    Kiuchi, Yoshiaki
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [29] The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure
    Adamsons, I
    Clineschmidt, C
    Polis, A
    Taylor, J
    Shedden, A
    Laibovitz, R
    JOURNAL OF GLAUCOMA, 1998, 7 (04) : 253 - 260
  • [30] OCULAR HYPOTENSIVE EFFECTS OF 0.5-PERCENT CARTEOLOL VERSUS 0.1-PERCENT TIMOLOL IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE (IOP)
    ALLAIRE, C
    TRINQUAND, C
    NORDMANN, JP
    DASCOTTE, JC
    GEORGE, JL
    LESURE, P
    ROULAND, JF
    KHAITRINE, L
    SIRBAT, D
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 1995, 18 (01): : 22 - 26
12345